It’s become a bit of a tradition for the Foundation to send a Thanksgiving note, and this year we’re excited to support projects that have evolved as part of ongoing work by researchers and the Foundation.

As you know, we seek new ideas and collaborative approaches and in 2021 that has translated into: continued work with NIH supporting next generation research, funding an initial site for breast cancer treatment clinical trial from the lab of Andrea Bild, Ph.D., at City of Hope, helping personalize radiation therapy for breast cancer with Heiko Enderling, Ph.D., at Moffitt Cancer Center, as well as extending funding to further the PhysiCell project developed by Paul Macklin, Ph.D.

The Foundation again hosted its annual October symposium, highlighting findings from collaborative research and hear a keynote address from the Jayne Koskinas Annual Keynote Speaker, Lisa M. Coussens, Ph.D. And I would be remiss if I didn’t thank Team TGM for its ongoing support.

Enjoy Thanksgiving with friends and loved ones and thank you again for being part of JKTG’s work. Happy Thanksgiving!

– Ted

Ted Giovanis, FHFMA, MBA
President and Founder
JKTG Foundation

Featured news

Targeting effective treatments for triple-negative breast cancer

Targeting effective treatments for triple-negative breast cancer

The JKTG Foundation recently awarded funding to Laura Heiser, Ph.D., Associate Professor and Vice Chair of Biomedical Engineering at the Oregon Health & Science University (OHSU) School of Medicine, to develop a prototype multiscale model designed to predict therapeutic responses of tumor ecosystems – a new frontier in breast cancer research.

read more

Jayne Koskinas Ted Giovanis
Foundation for Health and Policy

PO Box 130
Highland, Maryland 20777

Media contact: 202.548.0133